SKI Market

A+| A| A-|

Indian Indices

Sensex

77,461.88 2,845.30
( 3.81%)

Global Indices

Nasdaq

46,614.19 -76.70
(-0.16%)

Dow Jones

6,639.23 6.40
(0.10%)

Hang Seng

56,345.93 2,916.37
(5.46%)

Nikkei 225

10,352.49 -83.80
(-0.80%)

Forex

USD-INR

92.93 0.25
(0.27%)

EUR-INR

107.23 0.49
(0.46%)

GBP-INR

122.94 0.71
(0.58%)

JPY-INR

0.58 0.00
(0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gujarat Themis Biosyn Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

506879

INE942C01045

24.267589

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUJTHEM

60.06

2872.87

EPS(TTM)

Face Value()

Div & Yield %

4.39

0.25

Back

Board of Balkrishna Industries recommends Third Interim dividend

Jan 29,2026

Balkrishna Industries announced that the Board of Directors of the Company at its meeting held on 28 January 2026, inter alia, have recommended the Third Interim dividend of Rs 4 per equity Share (i.e. 200%) , subject to the approval of the shareholders.

77,461.88 2,845.30 ( 3.81%)

46,614.19 -76.70 (-0.16%)

6,639.23 6.40 (0.10%)

56,345.93 2,916.37 (5.46%)

10,352.49 -83.80 (-0.80%)

92.93 0.25 (0.27%)

107.23 0.49 (0.46%)

122.94 0.71 (0.58%)

0.58 0.00 (0.32%)